학술논문
The difference between concealment and blinding in clinical trials and why both are important. A reply to Garg and Mickenautsch, BMC Medical Research Methodology (2022) 22:17.
Document Type
Report
Author
Lyden P; Department of Physiology and Neuroscience, Zilkha Neurogenetic Institute of the Keck School of Medicine at USC, 1501 San Pablo Street, ZNI Room 245, Los Angeles, CA, 90033, USA. plyden@usc.edu.; Broderick J; University of Cincinnati Gardner Neuroscience Institute, Cincinnati, OH, USA.; Grotta J; Memorial Hermann Hospital, Texas Medical Center, Houston, TX, USA.; Kwiatkowski T; Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA.; Levine S; State University of New York Downstate Health Sciences University, Brooklyn, NY, USA.; Frankel M; Emory University School of Medicine, Marcus Stroke & Neuroscience Center at Grady Memorial Hospital, Atlanta, GA, USA.; Haley EC; University of Virginia, Charlottesville, VA, USA.; Tilley B; Department of Biostatistics and Bioinformatics, University of Texas Health Science Center, School of Public Health at Houston, Houston, TX, USA.
Source
Publisher: BioMed Central Country of Publication: England NLM ID: 100968545 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2288 (Electronic) Linking ISSN: 14712288 NLM ISO Abbreviation: BMC Med Res Methodol Subsets: MEDLINE
Subject
Language
English